[1] 张桂芳, 刘真亚, 高石娟,等. 以脑卒中健康管理师为主导的健康教育在缺血性脑卒中患者治疗依从性中的应用[J]. 黑龙江中医药, 2021, 50(5):100-103.
[2] Park D, Kang JS, Kim HS .Chronic phase survival rate in stroke patients with severe functional limitations according to the frequency of rehabilitation treatment[J].Arch Phys Med Rehabil, 2023, 104(2):251-259.
[3] 陈美芬, 王苏英, 冯小红, 等. 不同年龄和性别脑卒中高危人群的危险因素调查分析[J]. 实用预防医学, 2020, 27(4): 451-454.
[4] Kwon HS, Lee D, Lee MH, et al.Post-stroke cognitive impairment as an independent predictor of ischemic stroke recurrence: PICASSO sub-study[J]. J Neurol, 2020, 267(3): 688-693.
[5] Xia X, Yue W, Chao B, et al.Prevalence and risk factors of stroke in the elderly in Northern China:Data from the National Stroke Screening Survey[J].J Neurol, 2019, 266(6): 1449-1458.
[6] 温程娟. 脑卒中危险因素初筛量表信效度检验及发病风险研究[D].广州:广州医科大学, 2015.
[7] 中国高血压防治指南修订委员会.中国高血压防治指南2010[J].中华心血管病杂志,2011,39(7):579-616.
[8] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指(2016年修订版)[J].中国循环杂志,2016,31(10):937-950.
[9] 安玉, 周毅恒, 王晓锋, 等. 2013—2015年度大连市脑卒中高危人群危险因素的暴露情况分析[J]. 实用预防医学, 2020, 27(1): 5-8.
[10] Hankey GJ.Population impact of potentially modifiable risk factors for stroke[J]. Stroke, 2020, 51(3): 719-728.
[11] Wu H, Liu Y, Miao G,et al.Effect of the interaction between atrial fibrillation and rt-PA dose on the prognosis of acute ischaemic stroke with intravenous thrombolysis[J].Postgraduate Med J, 2022, 99(1172): 588-594.
[12] 刘震宇, 姚淑芳, 代宇洁, 等. 中老年城乡居民脑卒中高危人群筛查及危险因素[J]. 中国老年学杂志, 2020, 40(19): 4227-4230.
[13] 颜玮, 李中坚, 陈轶英, 等. 江西省40岁及以上常住居民脑卒中高危人群及其危险因素流行现状分析[J]. 现代预防医学, 2021, 48(12): 2130-2134.
[13] 卫玉齐, 王瑞瑞, 杨霞,等. 脑卒中吸烟患者尼古丁依赖现状及影响因素分析[J]. 护理学报, 2022(018):1-5.
[14] Nakayama R, Takaya Y, Akagi T, et al.Identification of high-risk patent foramen ovale associated with cryptogenic stroke: Development of a scoring system[J].J Am Soc Echocardiogr, 2019, 32(7): 811-816.
[15] 余溯源, 刘延锦, 郭丽娜, 等. 郑州市农村地区脑卒中家族史人群脑卒中危险因素调查分析[J]. 实用医学杂志, 2019, 35(3): 9-12.
[16] Abraham G, Malik R, Yonova-Doing E, et al. Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke[J]. Nat Commun, 2019, 10(1): 1-10.
[17] 黄学, 褚爱群, 杨智鹏, 等. 老年脑卒中高危人群多重危险因素共患情况分析[J]. 中西医结合心脑血管病杂志, 2022, 20(20): 3794-3796.
[18] Svendsen JH, Diederichsen SZ, Højberg S, et al.Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study):A randomised controlled trial[J]. Lancet, 2021, 398(10310): 1507-1516.
[19] 霍勇,秦献辉,张岩,等. 中国脑卒中一级预防研究的意义与进展[J]. 中国医学前沿杂志(电子版), 2013,5( 2) : 1-4.
[20] Toyoda K, Uchiyama S, Yamaguchi T, et al.Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan:A multicentre, open-label, randomised controlled trial[J]. Lancet Neurol, 2019, 18(6): 539-548.
[21] Gladstone DJ, Lindsay MP, Douketis J, et al.Canadian stroke best practice recommendations: Secondary prevention of stroke update 2020[J]. Can J Neurol Sci, 2022, 49(3):315-337.
[22] 顾竞春, 李勤, 顾怡勤. 社区脑卒中高危人群筛查的信息化探索与建议[J]. 中国全科医学, 2017, 20(26):178-179.
[23] 魏艳丽, 张开宇, 王凤玲,等. 佳木斯郊区老年脑卒中高危人群危险因素分析[J]. 中西医结合心脑血管病杂志, 2020,18(16):2733-2735.
[24] George MG.Risk factors for ischemic stroke in younger adults: A focused update[J]. Stroke, 2020, 51(3): 729-735.
[25] 赵钢. 脑卒中防治与血压管理[J].中华高血压杂志,2013,21(2) : 112-115.
[26] 马林,巢宝华,曹雷,等. 2007—2017年中国脑卒中流行趋势及特征分析[J]. 中华脑血管病杂志(电子版),2020,14(5):253-258. |
